IUCT Oncopôle

Futó vizsgálatok

• Még nem toboroz

  Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy

  NCT07814001· 2. fázis· Forrás

• Még nem toboroz

  Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia

  NCT07386392· Forrás

• Toboroz

  A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

  NCT06782373· 2. fázis· Forrás

• Toboroz

  Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma

  NCT06738797· Forrás

• Toboroz

  Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

  NCT06271057· 2. fázis· Forrás

• Toboroz

  Study of REM-422 in Patients With AML or Higher Risk MDS

  NCT06297941· 1. fázis· Forrás

• Fut, nem toboroz

  Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

  NCT05768711· 2. fázis· Forrás

• Toboroz

  Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy

  NCT05944913· Forrás

• Fut, nem toboroz

  Prevention of Alopecia in Patients With Localised Breast Cancer

  NCT06011525· Forrás

• Toboroz

  Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

  NCT05246345· Forrás

• Fut, nem toboroz

  Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

  NCT04802590· 2. fázis· Forrás

• Toboroz

  Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

  NCT04698785· 2. fázis· Forrás

• Fut, nem toboroz

  Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

  NCT03915678· 2. fázis· Forrás

• Fut, nem toboroz

  A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

  NCT03223961· 3. fázis· Forrás

• Fut, nem toboroz

  Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

  NCT03049189· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Akut mieloid leukémia (AML)2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Szarkóma2 toboroz
• Follikuláris limfóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Hólyagrák1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  NCT05091424· 1. fázis· Forrás

• Lezárult

  Targeting ATR in Soft-tissue Sarcomas

  NCT04807816· 2. fázis· Forrás

• Lezárult

  A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

  NCT04822350· Forrás

• Leállították

  Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

  NCT04778397· 3. fázis· Forrás

• Lezárult

  Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

  NCT04703686· 2. fázis· Forrás

• Toboroz

  A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  NCT04710576· 2. fázis· Forrás

• Lezárult

  Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

  NCT03249870· 2. fázis· Forrás

• Lezárult

  Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

  NCT02757989· Forrás

• Lezárult

  French Registry of First-line Treatment of Acute Promyelocytic Leukemia

  NCT02938858· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Forrás